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Abstract: Intermittent claudication (IC) is a common condition which is associated 
with significant quality of life limitation. NICE guidelines recommend a group based 
supervised exercise programme as the primary treatment option for claudication, 
based on clinical and cost effectiveness. This review aims to assess the mechanisms 
by which exercise improves outcomes in patients with intermittent claudication  
Methods: Medline, Embase and PubMed were searched using the search strategy 
'claudication' [AND] 'exercise' [AND] 'mechanisms'. Searches were limited from 
1947 to October 2014. Only full text articles published in the English language in 
adults (over 18 years of age) were eligible for the review. Any trial involving a non-
supervised exercise programme was excluded. Abstracts identified by the database 
search were interrogated for relevance and citations from the shortlisted papers 
were hand searched for relevant references. 
Results: The search yielded a total of 112 studies, of which 42 were duplicates. Forty 
seven of the remaining 70 were deemed appropriate for inclusion in the review. 
Exercise is the first line treatment for intermittent claudication. Supervised exercise 
programs improve walking distances; endothelial and mitochondrial function, 
muscle strength and endurance. Furthermore, it leads to a generalised improvement 
in cardiovascular fitness and overall quality of life.  
Conclusion: The mechanism by which exercise improves outcome in claudicants are 
complicated and multifactorial. Further research is required in this area to fully 
elucidate the precise and predominant mechanisms and to assess whether targeted 
exercise programme modification maximises mechanism efficacy and patient 
outcome.   
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Abstract: Intermittent claudication (IC) is a common condition which is associated with 1 
significant quality of life limitation. NICE guidelines recommend a group based supervised 2 
exercise programme as the primary treatment option for claudication, based on clinical and 3 
cost effectiveness. This review aims to assess the mechanisms by which exercise improves 4 
outcomes in patients with intermittent claudication  5 
 6 
Methods: Medline, Embase and PubMed were searched using the search strategy 7 
‘claudication’ [AND] ‘exercise’ [AND] ‘mechanisms’. Searches were limited from 1947 to 8 
October 2014. Only full text articles published in the English language in adults (over 18 9 
years of age) were eligible for the review. Any trial involving a non-supervised exercise 10 
programme was excluded. Abstracts identified by the database search were interrogated for 11 
relevance and citations from the shortlisted papers were hand searched for relevant 12 
references. 13 
 14 
Results: The search yielded a total of 112 studies, of which 42 were duplicates. Forty seven 15 
of the remaining 70 were deemed appropriate for inclusion in the review. Exercise is the first 16 
line treatment for intermittent claudication. Supervised exercise programs improve walking 17 
distances; endothelial and mitochondrial function, muscle strength and endurance. 18 
Furthermore, it leads to a generalised improvement in cardiovascular fitness and overall 19 
quality of life.  20 
 21 
Conclusion: The mechanism by which exercise improves outcome in claudicants is 22 
complicated and multifactorial. Further research is required in this area to fully elucidate the 23 
precise and predominant mechanisms and to assess whether targeted exercise programme 24 
modification maximises mechanism efficacy and patient outcome.   25 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 2
Introduction 26 
Intermittent claudication (IC), ischaemic muscle pain precipitated by exertion is the most 27 
common presenting symptom of peripheral arterial disease, affecting 5% of the population 28 
>50 years1-3. It was first described and defined by G.A Rose in 1962 with the following 29 
characteristics; (1) pain to include one or both calves, (2) provoked by hurrying or walking 30 
uphill, (3) never occur at rest, (4) must make the person stop, (5) disappear on a majority of 31 
occasions in 10 minutes or less, (6) and never disappear if walking continues 4. Claudication 32 
is therefore, frequently associated with a substantial reduction in walking capacity5, 6, 33 
significant deterioration in quality of life, balance impairment, and diminished physical 34 
function and activity levels7-10. A previous meta-analysis demonstrated that claudication 35 
distance varies between patients and between research trials, with ranges from 56m to 309m 36 
prior to starting an exercise treatment11. The data regarding patient recovery time is limited 37 
however it appears that on average patients require 3 minutes rest 12 to alleviate pain.  38 
 39 
 Initial treatment guidance for IC was to “go home and walk” later termed unsupervised 40 
exercise13. A Cochrane review6 has demonstrated however, that unsupervised programmes 41 
have inferior outcomes in comparison to supervised programmes in terms of improvements in 42 
walking distance, claudication onset and adherence to treatment. Therefore NICE clinical 43 
guideline 147 recommends a group-based supervised exercise programme (SEP) as first line 44 
treatment for patients with IC6, 14. Consequently supervised exercise programmes for 45 
claudication have been demonstrated to improve walking distances, quality of life, physical 46 
function, balance and be cost effective15. There is however, no general consensus on what 47 
should be included in the exercise programmes resulting in significant variability between 48 
studies. There is a general consensus that exercise programmes should be supervised, 49 
comprise of intermittent walking to near maximal pain at least three times per week16 for a 50 
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minimum of 12 weeks17. There is less agreement on the most effective intensity and modality 51 
of exercise in this scenario.  52 
 53 
It is clear that supervised exercise improves functional outcomes in claudicants; however the 54 
underlying mechanisms precipitating this change remain unclear. There seems little evidence 55 
of major haemodynamic changes18 therefore attention has shifted to the investigation of other 56 
potential mechanisms including skeletal muscle metabolism, cardiorespiratory function 57 
(resting heart rate, VO2 max, anaerobic threshold and endothelial (dys)function19. This 58 
review aims to examine the known evidence supporting the various potential mechanisms by 59 
which exercise improves outcome in patients with intermittent claudication.   60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
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Methods 76 
Search strategy  77 
All randomised and non-randomised trials were included of a supervised exercise regimen 78 
and a specific claudication mechanism. 79 
Inclusion criteria 80 
Trials involving patients with IC were included (diagnosed either clinically or by 81 
questionnaire). Any study involving patients who had prior endovascular intervention or 82 
undertaking an unsupervised exercise programme was excluded. Any intervention that 83 
included an exercise programme was included and the inclusion was not affected by the 84 
duration, length or time of the programme. This review will also consider any differences due 85 
to resistance versus aerobic exercise.  86 
Data extraction 87 
The main outcome measures are improvements in, blood flow, muscle strength, muscle 88 
power, muscle architecture, mitochondrial and muscular function and endothelial function. 89 
Database search 90 
Three databases; Medline, Embase, and PubMed were searched using the following search 91 
strategy: ‘claudication’ [AND], exercise [AND] mechanisms. Searches were limited to run 92 
from 1947 to 2014 using Ovid online in September 2014, with a second search conducted in 93 
October 2014 to ensure any new research was included. Only full text articles published in 94 
the English language in adults (over 18 years of age) were eligible for the review. Any trial 95 
involving a non-supervised exercise programme or home exercise programme was excluded 96 
20-23
. Abstracts identified by the database search were interrogated for relevance by two 97 
independent reviewers. Citations from the shortlisted papers were hand searched for other 98 
relevant references.  99 
 100 
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Results  101 
Search results 102 
The search yielded a total of 112 studies, of which 42 were duplicates. Of the remaining 70, 103 
47 were deemed appropriate for inclusion in the review. Of the specific exercise papers 40 104 
used aerobic conditioning and seven studies included some form of resistance training (see 105 
figure one) 106 
 107 
The aim of this review is to present a summary of the potential local mechanisms by which 108 
exercise is thought to improve functional outcome in patients with intermittent claudication, 109 
specifically in studies involving supervised exercise programmes only.  110 
 111 
 112 
 113 
 114 
 115 
 116 
 117 
 118 
 119 
 120 
 121 
 122 
 123 
 124 
 125 
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 Neurohumoral Effect 126 
The cardiovascular response to exercise includes an elevation in heart rate and increased 127 
sympathetic activation; this is known as the exercise pressor reflex. The afferent nerve fibres 128 
(group III, and IV)24 are stimulated by mechanical and metabolic stimuli from the exercising 129 
muscles, and activate the sympathetic nervous system (increases heart rate, blood pressure, 130 
myocardial contractility, and peripheral vasoconstriction). In particular the blood pressure 131 
response is significantly exaggerated in patients with PAD25, with values similar to that seen 132 
during resistance based exercise in age matched healthy controls. Systolic blood pressure was 133 
dramatically increased during exercise with some values even exceeding 300mmHg. This 134 
response has been associated with increasing disease severity as well as increased walking 135 
speed and duration of walking26. The exaggerated exercise pressor reflex and sympathetic 136 
overdrive may partially account for the excessive activation of these receptors, and thereby 137 
causing vasoconstriction and reduced blood flow, responsible for the reduction in walking 138 
distance and pain whilst walking, significantly contributing to symptoms.    139 
 140 
 Calf blood flow 141 
It is well documented that a SEP for claudication improves walking distance, however 142 
analysis of associated lower limb hemodynamic measures produce somewhat conflicting 143 
results. Venous occlusion plethysmography and ankle-brachial pressure index are the two 144 
most common documented methods of measuring calf blood flow with the venous occlusion 145 
plethysmography appearing a more sensitive measure27. Whilst both have been found to 146 
correlate moderately with patients walking distance 20, 28, improvements in walking distances 147 
with SEP are not reflected in significant improvements in either ankle-brachial pressure index 148 
or calf blood flow29. Only two out of the 47 reviewed papers reported a significant 149 
improvement in ankle-brachial pressure index at six16, 30 and 18 weeks after a SEP, 150 
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additionally a review conducted by Parmenter et al (2010) found no improvements in lower 151 
limb hemodynamic secondary to exercise in 33 trials. This suggests that whilst that ankle-152 
brachial pressure index may be valuable in the diagnosis of claudication, it is not responsive 153 
to change in clinical symptoms with SEP, it may however be relevant for those patients 154 
undergoing angioplasty31. There is disputed evidence regarding calf muscle oxygen 155 
saturation32 some studies show no improvement following an exercise programme, whereas 156 
others report significant change33. Given that the evidence is disputed it seems unlikely that 157 
improvement in calf blood flow has a significant role to play in the mechanism by which SEP 158 
improves outcome in patients with IC.  159 
 160 
Angiogensis 161 
Exercise is hypothesised to improve the collateral circulation and produce a “natural bypass” 162 
in claudicants. The growth factors implicated in formation of new vessels are vascular 163 
endothelial growth factor (VEGF) and fibroblast growth factors (FGF). In vitro and in-vivo 164 
studies have demonstrated VEGF and FGF to promote angiogenesis, endothelial proliferation 165 
and increase vascular permeability34. Animal models of lower limb ischaemia (by femoral 166 
artery ligation) report; a 43% improved regional blood flow with exercise35-37, an increase in 167 
the diameter of collateral blood vessels and up-regulation of VEGF38. Gene therapy to 168 
promote neovascularisation has restored blood flow in mouse models with ischaemic hind 169 
limbs 39  170 
 171 
In humans with lower limb ischaemia, exercise has not induced the same angiogenic 172 
response. Patients with PAD have reduced levels of VEGF-A, and its receptor VEGF-R1 and 173 
increased levels of anti-angiogenic factor VEGF165b40. Artificial supplementation of 174 
adenoviral vascular endothelial growth factor gene (AdVEGF121) has no effect on walking 175 
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ability or blood flow41. It is therefore unlikely that in humans with IC any significant 176 
angiogenesis occurs with supervised exercise. 177 
 178 
Haemorheology. 179 
Patients with PAD have significantly increased blood viscosity compared to controls42. 180 
Randomised controlled trials have shown a significant improvement in blood and plasma 181 
viscosity43 back to that of age matched healthy controls, and red cell deformability44 after a 182 
period of exercise training in patients with PAD. Pharmacological interventions to improve 183 
haemorrheology by haemodilution45 or pentoxifylline46 however, do not result in the same 184 
improvements in walking distance that are seen with SEP 47. 185 
 186 
Endothelial Function 187 
Flow mediated dilation is the gold standard assessment of endothelial function48, 49. The 188 
endothelium plays a crucial role in the regulation of vascular tone and blood flow via its 189 
production of nitric oxide (NO) by endothelial NO synthase. Physiologically stress from the 190 
viscous drag of blood flow is the most important stimulus for continuous formation of NO50. 191 
Released from endothelial cells, NO is rapidly transported to the neighbouring vascular 192 
smooth muscle cells, where it induces the production of cGMP as a second messenger. 193 
CGMP in turn increases calcium ion uptake into intracellular calcium stores, thereby 194 
inducing vascular smooth muscle cells relaxation and vasodilation. On its way to the vascular 195 
smooth muscle cells NO may be prematurely degraded by reactive oxygen species. The 196 
regulation of NO synthesis occurs at different levels: ENOS gene polymorphisms are related 197 
to eNOS expression & activity, mRNA expression is influenced by oestrogen status & shear 198 
stress, and enzyme activity is regulated by phosphorylation status. Flow mediated dilatation 199 
utilises reactive hyperaemia, the change in vessel diameter in response to a period of 200 
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ischemia as a surrogate marker for the endothelial function51.  This change in vessel diameter 201 
is a predictor of overall cardiovascular mortality48, 49. Patients with IC have an impaired flow 202 
mediated dilatation50 in comparison to age matched healthy controls, which significantly 203 
improves after an exercise programme from 4.81 to 7.97 (p <0.005)50, 52. This is potentially 204 
related to the exercise associated bouts of increased laminar flow up regulating eNOS mRNA 205 
expression and phosphorylation and antioxidant protection53. Furthermore the exercise 206 
modality appears to have an impact on the degree of flow mediated dilatation improvement 207 
with aerobic being superior to resistance training54. However, given the lack of data within 208 
this specific patient population it is difficult to draw definitive conclusions as to whether this 209 
is a significant mechanism for the symptomatic improvement with exercise in claudicants. It 210 
does appear however, to be a strong candidate for a mechanism of change.  211 
 212 
Mitochondrial and muscular function 213 
 Metabolites 214 
Muscle ischemia secondary to PAD results in a higher muscle metabolic demand at rest, 215 
exercise results in an early accumulation of metabolic intermediates such as acylcarnitines in 216 
both the muscle and plasma. Human studies of muscle metabolism generally necessitate a 217 
muscle biopsy, and thus usually only contain a small number of participants due to the 218 
invasive nature of the procedure. However they have demonstrated claudicants to have a 219 
higher lactate and, acylcarnitine levels in comparison to controls2. The concentration of the 220 
metabolite acylcarnitine was also identified to be inversely proportional to maximum walking 221 
distance (r=-0.75, p<0.05)2. With a period of exercise training, both metabolites reduced in 222 
concentrations whilst walking distances improved27, 55. It appears that L-carnitine allows 223 
ischemic muscle to reach a higher level of energy expenditure before the pain of claudication 224 
develops56. The administration of L-carnitine to patients both orally and / or intravenously 225 
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demonstrates a moderate improvement in walking ability56-58. However more research is 226 
required to determine to optimal dose, duration and safety of supplementation and if it’s 227 
supplementation is more beneficial than the current exercise programmes. Furthermore if 228 
exercise already lowers acylcarnitne and increases L-carnitine levels, it must be questioned 229 
whether having an additional supplementary dose is of any benefit to the PAD exercising 230 
population. However, it may be one alternative therapy to those who decline to participate in 231 
an exercise programme.  232 
 233 
 Mitochondria 234 
Patients with PAD compensate for the higher metabolic demand on skeletal muscle via an 235 
increase in mitochondrial density and activity compared to healthy controls59, 60. 236 
Concurrently, the ischemia and inflammatory response, results in both morphological 237 
alterations 61-63 and DNA damage64 to the mitochondria. One randomised control trial, which 238 
administered carbon monoxide to patients with PAD, resulted in a quicker onset of 239 
claudication, hypothesised to be secondary to impaired oxygen extraction and utilisation via 240 
the abnormal mitochondriae65. However, the effect of exercise on muscle metabolism at the 241 
cellular level remains uncertain at a higher exercising capacity 2, 66. Surgical revascularisation 242 
results in a reversal of the elevated activity of the mitochondrial activity back to that of 243 
healthy controls67, providing the bypass remains patent. Hypoxia is considered to be the 244 
mechanism driving mitochrondrial up-regulation and a randomised controlled trial 245 
demonstrated that administration of Pentoxifylline also improves mitochondrial function68. 246 
However, this improvement occurred without change in blood flow and therefore, is most 247 
likely due to a change in intrinsic mitochondrial oxidative activity. 248 
 249 
 250 
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Muscle architecture  251 
Lower limb calf muscle architecture in claudicants comprises a higher fat percentage and a 252 
lower muscle cross sectional area compared to healthy controls69, 70. There is also a reduction 253 
in the proportion of Type 1 muscle fibres69, 70 which have the greatest oxidative capacity and 254 
are, therefore important in aerobic endurance. In addition the number of capillaries per 255 
muscle fibre is reduced71, apoptosis is increased72, glucose uptake is impaired73 and atrophy 256 
may occur74. In murine models of ischemia, exercise training was associated with improved 257 
muscle development, with associated improvements in peak oxygen uptake compared to 258 
sedentary controls75. Additionally human studies have demonstrated an improvement in 259 
mitochondrial content post-training as a contributing factor for training-induced performance 260 
improvements76, 77. Walking distances are not significantly affected by different exercise 261 
modalities, although resistance training produced greater improvement in muscle bulk and 262 
composition compared to aerobic exercise78. This occurs via an increase in type IIa fibres, 263 
capillary density and improvement in muscular function22, 79. The change in muscle 264 
architecture is perhaps one likely mechanism for improved walking distances in patients with 265 
IC.  266 
 267 
 Muscular Strength & Endurance 268 
The current recommendations for IC include walking to a moderate-high level of pain 80, 269 
however exercise therapy guidelines vary amongst published literature. Consequently, much 270 
attention has been given to aerobic or treadmill walking in patients with IC, with few 271 
acknowledging how resistance training may be beneficial. Indeed only 15% 54, 79, 81-86 of all 272 
47 exercise studies in this review had some form of resistance training. Crucially, some 273 
patients are unwilling and / or unable to undertake aerobic training87. A systematic review in 274 
2014 showed that clinically relevant improvements are demonstrated with both aerobic, 275 
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resistance training and / or a mixture of both87. Further, there is a definitive lack of data 276 
regarding muscular strength and endurance in patients with PAD. One study showed that one 277 
repetition leg strength was significantly increased following a strength training programme, 278 
which in turn led to improvements in walking economy and walking performance86. There is 279 
also a potentially strong association between change in plantar flexor muscle strength and 280 
walking ability54, 79, 84, 88. Secondary to this resistance exercise does not promote the classic 281 
“walking to pain” and could potentially improve uptake and compliance to an exercise 282 
programme, although this is yet to be assessed, in comparison to classic treadmill and aerobic 283 
exercise89  284 
 285 
Intra-Muscle Inflammatory Cascade 286 
Evidence suggests that inflammatory cascade induced by exercising to pain may have a 287 
detrimental effect on both the endothelium90, 91 and the muscle92. Ischemia – Reperfusion 288 
Injury is a possible consequence of exercise training in IC93 characterised by an inflammatory 289 
cascade and increased microvascular permeability94. The increase in pro-inflammatory 290 
cytokines is one potential mechanism for the impairment in endothelial function after 291 
exercise in PAD patients95.  Ischemic reperfusion injury causes a loss of calcium homeostasis 292 
leading to unregulated calcium activated enzymes, including the calpain system. Skeletal 293 
muscle exhibits u-calpain, m-calpain and calpain-3, which are activated following exercise96. 294 
These activated calpains can cause morphological damage to the skeletal muscle96 and cell 295 
death97. Murine models support the pathway between calpain-induced muscle wasting and 296 
PAD, which was more severe in the exercising training model98. This suggests that classic 297 
aerobic training may prevent the maintenance of muscular mass in claudicants.  298 
 299 
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The importance of preserving muscle mass is well documented and is important in balance74, 300 
functional daily activities and overall quality of life99. Treadmill-based exercise has been 301 
associated with an increase in calpain proteolytic activity and a relative reduction in the 302 
skeletal muscle size92. Although the study was small (n=35) it demonstrates that treadmill 303 
based aerobic exercise may be detrimental due to the increase in catabolic muscle wasting 304 
therefore reducing the skeletal muscle mass. It is clear that the prescription of an exercise 305 
programme must be focused on achieving the relevant clinical outcomes but awareness of the 306 
potential negative physiological consequence. However, studies have demonstrated that 307 
exercise training has no detrimental effects at 12 month follow-up91. There is some evidence 308 
suggesting that resistance training maintains muscle mass whilst achieving similar clinical 309 
benefits to aerobic exercise87, 92, 100. 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
 320 
 321 
 322 
 323 
 324 
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Conclusion 325 
This review provides a summary of the potential mechanisms which by which exercise 326 
improves outcome in claudicants, highlighting areas of uncertainty. It would seem that the 327 
traditional beliefs that exercise in claudicants promote new blood vessel formation and 328 
improved blood flow is unlikely to be a major contributory mechanisms. Current evidence 329 
supports a multifactor aetiology, with the most likely mechanisms contributing to 330 
improvement including changes in cardio-respiratory physiology, endothelial function, 331 
mitochondrial number and activity and muscle conditioning. At present further research is 332 
required if we are to fully understand and maximise these mechanisms. In addition work is 333 
required to investigate how these mechanisms vary between different patient groups (e.g. 334 
responders & non responders) and between different training regimes (aerobic versus 335 
resistance) 336 
 337 
 338 
Despite the mechanism of exercise improvements remaining poorly understood, the clinical 339 
benefit to patients is clearly supported by the available evidence. A recent review and meta-340 
analysis in randomised controlled trials 101, 102 have demonstrated that patients compliant with 341 
a supervised exercise programme can expect maximum walking time and distance and pain-342 
free walking time and distance to be significantly increased with an associated significant 343 
improvement in the walking impairment questionnaire102 (specifically in aerobic training). In 344 
additional aerobic (walking) training improves the physical component of the SF36 but not 345 
the mental component. Importantly the benefit from a supervised exercise programme in 346 
claudicants seems to be sustained for up to two years103.  347 
 348 
 349 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 15
References  350 
1. Szuba A, Oka RK, Harada R, Cooke JP. Limb hemodynamics are not predictive of 351 
functional capacity in patients with PAD. Vasc Med. 2006;11(3):155-63. 352 
2. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP. Effect of exercise 353 
training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl 354 
Physiol. 1996;81(2):780-8. 355 
3. Lee HL, Mehta T, Ray B, Heng MS, McCollum PT, Chetter IC. A non-randomised 356 
controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for 357 
claudication. European Journal of Vascular and Endovascular Surgery. 2007;33(2):202-7. 358 
4. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field 359 
surveys. Bulletin of the World Health Organization. 1962;27:645-58. 360 
5. Beebe HG. Intermittent claudication: effective medical management of a common 361 
circulatory problem. The American Journal of Cardiology. 2001;87(12A):14D-8D. 362 
6. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise 363 
therapy versus non-supervised exercise therapy for intermittent claudication. The Cochrane 364 
database of systematic reviews. 2006(2):CD005263. 365 
7. Gardner AW, Ritti-Dias RM, Stoner JA, Montgomery PS, Scott KJ, Blevins SM. 366 
Walking economy before and after the onset of claudication pain in patients with peripheral 367 
arterial disease. Journal of Vascular Surgery. 2010;51(3):628-33. 368 
8. McDermott MM, Ferrucci L, Guralnik JM, Dyer AR, Liu K, Pearce WH, et al. The 369 
ankle-brachial index is associated with the magnitude of impaired walking endurance among 370 
men and women with peripheral arterial disease. Vasc Med. 2010;15(4):251-7. 371 
9. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, et al. 372 
Functional decline in peripheral arterial disease: associations with the ankle brachial index 373 
and leg symptoms. JAMA. 2004;292(4):453-61. 374 
10. Gohil RA, Mockford KA, Mazari F, Khan J, Vanicek N, Chetter IC, et al. Balance 375 
impairment, physical ability, and its link with disease severity in patients with intermittent 376 
claudication. Annals of Vascular Surgery. 2013;27(1):68-74. 377 
11. Gommans LN, Saarloos R, Scheltinga MR, Houterman S, de Bie RA, Fokkenrood HJ, 378 
et al. Editor's choice--The effect of supervision on walking distance in patients with 379 
intermittent claudication: a meta-analysis. European Journal of Vascular and Endovascular 380 
Surgery. 2014;48(2):169-84. 381 
12. King S, Vanicek N, Mockford KA, Coughlin PA. The effect of a 3-month supervised 382 
exercise programme on gait parameters of patients with peripheral arterial disease and 383 
intermittent claudication. Clinical Biomechanics. 2012;27(8):845-51. 384 
13. Cunningham MA, Swanson V, O'Carroll RE, Holdsworth RJ. Randomized clinical 385 
trial of a brief psychological intervention to increase walking in patients with intermittent 386 
claudication. The British Journal of Surgery. 2012;99(1):49-56. 387 
14. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. The Cochrane 388 
database of systematic reviews. 2008(4):CD000990. 389 
15. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of 390 
claudication pain. A meta-analysis. JAMA. 1995;274(12):975-80. 391 
16. Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR, et al. 392 
Exercise rehabilitation improves functional outcomes and peripheral circulation in patients 393 
with intermittent claudication: a randomized controlled trial. Journal of the American 394 
Geriatrics Society. 2001;49(6):755-62. 395 
17. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. 396 
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease 397 
(lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the 398 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 16
American Associations for Vascular Surgery/Society for Vascular Surgery, Society for 399 
Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, 400 
Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines 401 
(writing committee to develop guidelines for the management of patients with peripheral 402 
arterial disease)--summary of recommendations. JVIR. 2006;17(9):1383-97 403 
18. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Prediction of claudication pain 404 
from clinical measurements obtained at rest. Medicine and Science in Sports and Exercise. 405 
1992;24(2):163-70. 406 
19. McGuigan MR, Bronks R, Newton RU, Sharman MJ, Graham JC, Cody DV, et al. 407 
Muscle fiber characteristics in patients with peripheral arterial disease. Medicine and Science 408 
in Sports and Exercise. 2001;33(12):2016-21. 409 
20. Alpert JS, Larsen OA, Lassen NA. Exercise and intermittent claudication. Blood flow 410 
in the calf muscle during walking studied by the xenon-133 clearance method. Circulation. 411 
1969;39(3):353-9. 412 
21. Craft LL, Guralnik JM, Ferrucci L, Liu K, Tian L, Criqui MH, et al. Physical activity 413 
during daily life and circulating biomarker levels in patients with peripheral arterial disease. 414 
The American Journal of Cardiology. 2008;102(9):1263-8. 415 
22. Duscha BD, Robbins JL, Jones WS, Kraus WE, Lye RJ, Sanders JM, et al. 416 
Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral 417 
artery disease patients. Arteriosclerosis, thrombosis, and vascular biology. 2011;31(11):2742-418 
8. 419 
23. Tan KH, Cotterrell D, Sykes K, Sissons GR, de Cossart L, Edwards PR. Exercise 420 
training for claudicants: changes in blood flow, cardiorespiratory status, metabolic functions, 421 
blood rheology and lipid profile. European journal of vascular and endovascular surgery. 422 
2000;20(1):72-8. 423 
24. McCloskey DI, Mitchell JH. Reflex cardiovascular and respiratory responses 424 
originating in exercising muscle. The Journal of Physiology. 1972;224(1):173-86. 425 
25. Bakke EF, Hisdal J, Jorgensen JJ, Kroese A, Stranden E. Blood pressure in patients 426 
with intermittent claudication increases continuously during walking. European journal of 427 
vascular and endovascular surgery. 2007;33(1):20-5. 428 
26. Baccelli G, Reggiani P, Mattioli A, Corbellini E, Garducci S, Catalano M. The 429 
exercise pressor reflex and changes in radial arterial pressure and heart rate during walking in 430 
patients with arteriosclerosis obliterans. Angiology. 1999;50(5):361-74. 431 
27. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise 432 
conditioning for patients with peripheral arterial disease. Circulation. 1990;81(2):602-9. 433 
28. Skinner JS, Strandness DE, Jr. Exercise and intermittent claudication.II. Effect of 434 
physical training. Circulation. 1967;36(1):23-9. 435 
29. Parmenter BJ, Raymond J, Fiatarone Singh MA. The effect of exercise on 436 
haemodynamics in intermittent claudication: a systematic review of randomized controlled 437 
trials. Sports Med. 2010;40(5):433-47. 438 
30. Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term exercise 439 
rehabilitation on claudication distances in patients with peripheral arterial disease: a 440 
randomized controlled trial. Journal of Cardiopulmonary Rehabilitation. 2002;22(3):192-8. 441 
31. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus 442 
angioplasty for stable claudication. Long and medium term results of a prospective, 443 
randomised trial. European Journal of Vascular and Endovascular surgery. 1996;11(4):409-444 
13. 445 
32. Beckitt TA, Day J, Morgan M, Lamont PM. Calf muscle oxygen saturation and the 446 
effects of supervised exercise training for intermittent claudication. Journal of Vascular 447 
Surgery. 2012;56(2):470-5. 448 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 17
33. Gardner AW, Katzel LI, Sorkin JD, Killewich LA, Ryan A, Flinn WR, et al. 449 
Improved functional outcomes following exercise rehabilitation in patients with intermittent 450 
claudication. The journals of gerontology Series A, Biological sciences and medical sciences. 451 
2000;55(10):M570-7. 452 
34. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial 453 
growth factor and basic fibroblast growth factor on the proliferation and cord formation of 454 
bovine capillary endothelial cells within collagen gels. Laboratory investigation; a journal of 455 
technical methods and pathology. 1993;69(5):508-17. 456 
35. Mathien GM, Terjung RL. Muscle blood flow in trained rats with peripheral arterial 457 
insufficiency. The American Journal of Physiology. 1990;258(3 Pt 2):H759-65. 458 
36. Sunakawa M, Kohmoto T, Komoto Y. Evaluation of tissue perfusion in ischemic legs 459 
of dogs by CO2 clearance rate. Acta medica Okayama. 1989;43(1):47-54. 460 
37. Yang HT, Ogilvie RW, Terjung RL. Training increases collateral-dependent muscle 461 
blood flow in aged rats. The American Journal of Physiology. 1995;268(3 Pt 2):H1174-80. 462 
38. Prior BM, Lloyd PG, Ren J, Li H, Yang HT, Laughlin MH, et al. Time course of 463 
changes in collateral blood flow and isolated vessel size and gene expression after femoral 464 
artery occlusion in rats. American Journal of Physiology Heart and Circulatory Physiology. 465 
2004;287(6):H2434-47. 466 
39. Okamoto N, Tanaka A, Jung K, Karasawa K, Orito K, Matsuda A, et al. Silencing of 467 
int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial 468 
disease. Cardiovascular Research. 2011;92(2):209-17. 469 
40. Jones WS, Duscha BD, Robbins JL, Duggan NN, Regensteiner JG, Kraus WE, et al. 470 
Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in 471 
skeletal muscle of patients with intermittent claudication following exercise training. Vasc 472 
Med. 2012;17(2):94-100. 473 
41. Rajagopalan S, Mohler ER, 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, 474 
Goldman CK, et al. Regional angiogenesis with vascular endothelial growth factor in 475 
peripheral arterial disease: a phase II randomized, double-blind, controlled study of 476 
adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling 477 
intermittent claudication. Circulation. 2003;108(16):1933-8. 478 
42. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, 479 
haemodynamic, rheological, and biochemical findings in 126 patients with intermittent 480 
claudication. British Medical Journal. 1973;4(5892):576-81. 481 
43. Ernst EE, Matrai A. Intermittent claudication, exercise, and blood rheology. 482 
Circulation. 1987;76(5):1110-4. 483 
44. Mika P, Spodaryk K, Cencora A, Mika A. Red blood cell deformability in patients 484 
with claudication after pain-free treadmill training. Clinical Journal of Sport Medicine 485 
2006;16(4):335-40. 486 
45. Ernst E, Matrai A, Kollar L. Placebo-controlled, double-blind trial of hemodilution in 487 
peripheral occlusive arterial disease. Angiology. 1989;40(5):479-83. 488 
46. Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A. Effects of 489 
flunarizine and pentoxifylline on walking distance and blood rheology in claudication. 490 
Angiology. 1984;35(6):366-72. 491 
47. Creager MA. Medical management of peripheral arterial disease. Cardiology in 492 
review. 2001;9(4):238-45. 493 
48. Koller A, Huang A, Sun D, Kaley G. Exercise training augments flow-dependent 494 
dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. 495 
Circulation Research. 1995;76(4):544-50. 496 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 18
49. Miller VM, Vanhoutte PM. Enhanced release of endothelium-derived factor(s) by 497 
chronic increases in blood flow. The American Journal of Physiology. 1988;255(3 Pt 498 
2):H446-51. 499 
50. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise 500 
rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. The 501 
American Journal of Cardiology. 2001;87(3):324-9. 502 
51. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. 503 
Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric 504 
oxide. The American Journal of Physiology. 1996;270(4 Pt 2):H1435-40. 505 
52. Januszek R, Mika P, Konik A, Petriczek T, Nowobilski R, Nizankowski R. The effect 506 
of treadmill training on endothelial function and walking abilities in patients with peripheral 507 
arterial disease. Journal of Cardiology. 2014;64(2):145-51. 508 
53. Gielen S, Sandri M, Erbs S, Adams V. Exercise-induced modulation of endothelial 509 
nitric oxide production. Current pharmaceutical biotechnology. 2011;12(9):1375-84. 510 
54. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, et al. Treadmill 511 
exercise and resistance training in patients with peripheral arterial disease with and without 512 
intermittent claudication: a randomized controlled trial. JAMA. 2009;301(2):165-74. 513 
55. Sorlie D, Myhre K. Lower leg blood flow in intermittent claudication. Scandinavian 514 
Journal of Clinical and Laboratory Investigation. 1978;38(2):171-9. 515 
56. Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini A, et al. 516 
Increases in walking distance in patients with peripheral vascular disease treated with L-517 
carnitine: a double-blind, cross-over study. Circulation. 1988;77(4):767-73. 518 
57. Brevetti G, di Lisa F, Perna S, Menabo R, Barbato R, Martone VD, et al. Carnitine-519 
related alterations in patients with intermittent claudication: indication for a focused carnitine 520 
therapy. Circulation. 1996;93(9):1685-9. 521 
58. Delaney CL, Spark JI, Thomas J, Wong YT, Chan LT, Miller MD. A systematic 522 
review to evaluate the effectiveness of carnitine supplementation in improving walking 523 
performance among individuals with intermittent claudication. Atherosclerosis. 524 
2013;229(1):1-9. 525 
59. Pipinos, II, Judge AR, Zhu Z, Selsby JT, Swanson SA, Johanning JM, et al. 526 
Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free 527 
radical biology & medicine. 2006;41(2):262-9. 528 
60. Jansson E, Johansson J, Sylven C, Kaijser L. Calf muscle adaptation in intermittent 529 
claudication. Side-differences in muscle metabolic characteristics in patients with unilateral 530 
arterial disease. Clin Physiol. 1988;8(1):17-29. 531 
61. Brass EP, Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic 532 
peripheral arterial disease. Vasc Med. 2000;5(1):55-9. 533 
62. Brass EP, Wang H, Hiatt WR. Multiple skeletal muscle mitochondrial DNA deletions 534 
in patients with unilateral peripheral arterial disease. Vasc Med. 2000;5(4):225-30. 535 
63. Marbini A, Gemignani F, Scoditti U, Rustichelli P, Bragaglia MM, Govoni E. 536 
Abnormal muscle mitochondria in ischemic claudication. Acta neurologica Belgica. 537 
1986;86(5):304-10. 538 
64. Bhat HK, Hiatt WR, Hoppel CL, Brass EP. Skeletal muscle mitochondrial DNA 539 
injury in patients with unilateral peripheral arterial disease. Circulation. 1999;99(6):807-12. 540 
65. Aronow WS, Stemmer EA, Isbell MW. Effect of carbon monoxide exposure on 541 
intermittent claudication. Circulation. 1974;49(3):415-7. 542 
66. Lundgren F, Dahllof AG, Schersten T, Bylund-Fellenius AC. Muscle enzyme 543 
adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of 544 
different treatments and consequences on walking performance. Clin Sci (Lond). 545 
1989;77(5):485-93. 546 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 19
67. Zatina MA, Berkowitz HD, Gross GM, Maris JM, Chance B. 31P nuclear magnetic 547 
resonance spectroscopy: noninvasive biochemical analysis of the ischemic extremity. Journal 548 
of Vascular Surgery. 1986;3(3):411-20. 549 
68. Pipinos, II, Boska MD, Shepard AD, Anagnostopoulos PV, Katsamouris A. 550 
Pentoxifylline reverses oxidative mitochondrial defect in claudicating skeletal muscle. The 551 
Journal of Surgical Research. 2002;102(2):126-32. 552 
69. Askew CD, Green S, Walker PJ, Kerr GK, Green AA, Williams AD, et al. Skeletal 553 
muscle phenotype is associated with exercise tolerance in patients with peripheral arterial 554 
disease. Journal of Vascular Surgery. 2005;41(5):802-7. 555 
70. Hedberg B, Angquist KA, Henriksson-Larsen K, Sjostrom M. Fibre loss and 556 
distribution in skeletal muscle from patients with severe peripheral arterial insufficiency. 557 
European Journal of Vascular Surgery. 1989;3(4):315-22. 558 
71. Robbins JL, Jones WS, Duscha BD, Allen JD, Kraus WE, Regensteiner JG, et al. 559 
Relationship between leg muscle capillary density and peak hyperemic blood flow with 560 
endurance capacity in peripheral artery disease. J Appl Physiol (1985). 2011;111(1):81-6. 561 
72. Mitchell RG, Duscha BD, Robbins JL, Redfern SI, Chung J, Bensimhon DR, et al. 562 
Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral 563 
arterial disease. Vasc Med. 2007;12(4):285-90. 564 
73. Pande RL, Park MA, Perlstein TS, Desai AS, Doyle J, Navarrete N, et al. Impaired 565 
skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in 566 
patients with peripheral artery disease and intermittent claudication. Arteriosclerosis, 567 
thrombosis, and vascular biology. 2011;31(1):190-6. 568 
74. Mockford KA, Gohil RA, Mazari F, Khan JA, Vanicek N, Coughlin PA, et al. Effect 569 
of supervised exercise on physical function and balance in patients with intermittent 570 
claudication. The British Journal of Surgery. 2014;101(4):356-62. 571 
75. Erney TP, Mathien GM, Terjung RL. Muscle adaptations in trained rats with 572 
peripheral arterial insufficiency. The American Journal of Physiology. 1991;260(2 Pt 573 
2):H445-52. 574 
76. Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J. Effects of a 575 
6-month exercise program pilot study on walking economy, peak physiological 576 
characteristics, and walking performance in patients with peripheral arterial disease. Vascular 577 
health and risk management. 2012;8:225-32. 578 
77. Wang J, Zhou S, Bronks R, Graham J, Myers S. Effects of supervised treadmill 579 
walking training on calf muscle capillarization in patients with intermittent claudication. 580 
Angiology. 2009;60(1):36-41. 581 
78. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking 582 
exercise versus strength training for patients with peripheral arterial disease. Implications for 583 
the mechanism of the training response. Circulation. 1994;90(4):1866-74. 584 
79. McGuigan MR, Bronks R, Newton RU, Sharman MJ, Graham JC, Cody DV, et al. 585 
Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, 586 
fiber type distribution, and capillary supply to skeletal muscle. The journals of gerontology 587 
Series A, Biological sciences and medical sciences. 2001;56(7):B302-10. 588 
80. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-589 
Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of 590 
Vascular Surgery. 2007;45 Suppl S:S5-67. 591 
81. Johnson EC, Voyles WF, Atterbom HA, Pathak D, Sutton MF, Greene ER. Effects of 592 
exercise training on common femoral artery blood flow in patients with intermittent 593 
claudication. Circulation. 1989;80(5 Pt 2):III59-72. 594 
82. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status 595 
in patients with peripheral arterial disease. Journal of Vascular Surgery. 1996;23(1):104-15. 596 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 20
83. Ritti-Dias RM, Basyches M, Camara L, Puech-Leao P, Battistella L, Wolosker N. 597 
Test-retest reliability of isokinetic strength and endurance tests in patients with intermittent 598 
claudication. Vasc Med. 2010;15(4):275-8. 599 
84. Ritti-Dias RM, Wolosker N, de Moraes Forjaz CL, Carvalho CR, Cucato GG, Leao 600 
PP, et al. Strength training increases walking tolerance in intermittent claudication patients: 601 
randomized trial. Journal of Vascular Surgery. 2010;51(1):89-95. 602 
85. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. Upper- vs 603 
lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial 604 
disease: a randomized controlled trial. Journal of Vascular Surgery. 2005;42(6):1122-30. 605 
86. Wang E, Helgerud J, Loe H, Indseth K, Kaehler N, Hoff J. Maximal strength training 606 
improves walking performance in peripheral arterial disease patients. Scandinavian Journal of 607 
Medicine & Science in Sports. 2010;20(5):764-70. 608 
87. Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic review of randomized 609 
controlled trials: Walking versus alternative exercise prescription as treatment for intermittent 610 
claudication. Atherosclerosis. 2011;218(1):1-12. 611 
88. Slordahl SA, Wang E, Hoff J, Kemi OJ, Amundsen BH, Helgerud J. Effective 612 
training for patients with intermittent claudication. SCJ. 2005;39(4):244-9. 613 
89. Bronas UG, Hirsch AT, Murphy T, Badenhop D, Collins TC, Ehrman JK, et al. 614 
Design of the multicenter standardized supervised exercise training intervention for the 615 
claudication: exercise vs endoluminal revascularization (CLEVER) study. Vasc Med. 616 
2009;14(4):313-21. 617 
90. Andreozzi GM, Martini R, Cordova R, D'Eri A, Salmistraro G, Mussap M, et al. 618 
Circulating levels of cytokines (IL-6 and IL-1beta) in patients with intermittent claudication, 619 
at rest, after maximal exercise treadmill test and during restore phase. Could they be 620 
progression markers of the disease? International Angiology. 2007;26(3):245-52. 621 
91. Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP. Exercise training for 622 
intermittent claudication: does it adversely affect biochemical markers of the exercise-623 
induced inflammatory response? European Journal of Vascular and Endovascular Surgery. 624 
1997;14(5):344-50. 625 
92. Delaney CL, Miller MD, Chataway TK, Spark JI. A randomised controlled trial of 626 
supervised exercise regimens and their impact on walking performance, skeletal muscle mass 627 
and calpain activity in patients with intermittent claudication. European journal of vascular 628 
and endovascular surgery : the official journal of the European Society for Vascular Surgery. 629 
2014;47(3):304-10. 630 
93. Tisi PV, Shearman CP. Biochemical and inflammatory changes in the exercising 631 
claudicant. Vasc Med. 1998;3(3):189-98. 632 
94. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. British 633 
medical bulletin. 2004;70:71-86. 634 
95. Andreozzi GM, Leone A, Laudani R, Deinite G, Martini R. Acute impairment of the 635 
endothelial function by maximal treadmill exercise in patients with intermittent claudication, 636 
and its improvement after supervised physical training. International Angiology. 637 
2007;26(1):12-7. 638 
96. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiological 639 
reviews. 2003;83(3):731-801. 640 
97. Chen M, Won DJ, Krajewski S, Gottlieb RA. Calpain and mitochondria in 641 
ischemia/reperfusion injury. The Journal of Biological Chemistry. 2002;277(32):29181-6. 642 
98. Tsai YL, Hou CW, Liao YH, Chen CY, Lin FC, Lee WC, et al. Exercise training 643 
exacerbates tourniquet ischemia-induced decreases in GLUT4 expression and muscle atrophy 644 
in rats. Life sciences. 2006;78(25):2953-9. 645 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Exercise & Intermittent Claudication: A review.  
 21
99. Wolfe RR. The underappreciated role of muscle in health and disease. The American 646 
Journal of Clinical Nutrition. 2006;84(3):475-82. 647 
100. Parmenter BJ, Raymond J, Fiatarone Singh MA. The effect of exercise on fitness and 648 
performance-based tests of function in intermittent claudication: a systematic review. Sports 649 
Med. 2013;43(6):513-24. 650 
101. Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. The 651 
Cochrane database of systematic reviews. 2014;7:CD000990. 652 
102. Parmenter BJ, Dieberg G, Phipps G, Smart NA. Exercise training for health-related 653 
quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 654 
2015;20(1):30-40. 655 
103. Jansen T, Weiss T, Amendt K, Hsu E, Hubsch-Muller C, Diehm C. [Effect of a 2-year 656 
ambulatory vascular sports program on walking distance in claudication patients--a 657 
controlled study]. VASA Supplementum. 1991;33:175. 658 
 659 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
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